Al Shahrani M: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Person | {{Person | ||
|lastname=Al | |lastname=Al Shahrani | ||
|firstname=Mesfer | |firstname=Mesfer | ||
|institution=The National Hospital for Neurology & Neurosurgery | |institution=The National Hospital for Neurology & Neurosurgery | ||
| Line 12: | Line 12: | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
== Participated at == | == Participated at == | ||
* [[IOC100]] | * [[IOC100]] | ||
Revision as of 10:17, 31 March 2015
| Name | Al Shahrani Mesfer, |
|---|---|
| Institution | The National Hospital for Neurology & Neurosurgery
Neurometabolic Unit |
| Address | Queen Square, WC1N 3BG |
| City | London |
| State/Province | |
| Country | United Kingdom |
| mesfer.shahrani.14@ucl.ac.uk | |
| Weblink | |
| O2k-Network Lab | UK London Land JM |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Hargreaves 2016 Drug Saf | 2016 | Hargreaves IP, Al Shahrani M, Wainwright L, Heales SJR (2016) Drug-induced mitochondrial toxicity. Drug Saf 39:661–74. https://doi.org/10.1007/s40264-016-0417-x. |
